Copyright
©The Author(s) 2023.
World J Orthop. Jul 18, 2023; 14(7): 505-515
Published online Jul 18, 2023. doi: 10.5312/wjo.v14.i7.505
Published online Jul 18, 2023. doi: 10.5312/wjo.v14.i7.505
Ref. | Level of evidence | Design | Groups (n) | Injections/dosis | Outcomes measure | Follow-up | Conclusions |
Kesikburun et al[54], 2013 | I | Ultrasound-guided PRP injections vs saline injections | 40 patients PRP (20), placebo (20) | 1/5 mL | VAS, WORC, and SPADI | 3, 6, 12, 24 wk. 1 yr | PRP is not more effective in improving shoulder quality of life, pain, disability, and range of motion than placebo |
Rha et al[57], 2013 | I | PRP injections vs dry needling | 39 patients. PRP (20), dry needling (20) | 1/3 mL | SPADI, passive ROM, global rating scale, ultrasound measurement | 24 wk | PRP leads to a progressive reduction in pain and disability compared to dry needling |
Scarpone et al[59], 2013 | III | Ultrasound guided PRP injection at the lesion and surrounding tendon | 18 | 1/3.5 mL | MRI, VAS and three-item patient satisfaction scale | 8, 12, 52 wk | Improvement in MRI, pain and function with PRP |
Lee et al[62], 2019 | III | PRP injection vs exercise treatment; leukocyte-poor vs leukocyte-rich PRP | 60. PRP (27), exercise (33) | 1/1.5 mL | ASES, CMS, and NRS | 12 wk, 24 wk | PRP is more effective than exercise therapy for the first 3 mo |
Kim et al[55], 2019 | II | PRP injection vs exercise treatment | 30 patients. PRP (15), exercise (15) | 1/2 mL | ASES, CMS, and NRS | 12 wk, 24 wk | PRP had an advantage over exercise; improvement until 12 wk, slight decrease at 24 wk |
Rossi et al[71], 2021 | II | Subacromial PRP injections | 50 patients | 1/5 mL | ASES, CMS, and VAS | 1 yr | PRP decreased pain, improved functional outcomes, and resolved sleep disturbances. Return to sports for most athletes |
Oudelaar et al[77], 2021 | I | NACD + PRP vs NACD + CI | 88 patients. NACD + PRP (41), NACD + CI (47) | 1/5 mL | VAS, CMS, DASH, OSS, EQ-5D | 6 wk, 3 mo, 6 mo, 12 mo, 24 mo | NACD + PRP was worse at the 6-wk follow-up but better at the 6-mo follow-up. Comparable results at 12 and 24 mo |
- Citation: Velasquez Garcia A, Ingala Martini L, Franco Abache A, Abdo G. Role of platelet-rich plasma in the treatment of rotator cuff tendinopathy. World J Orthop 2023; 14(7): 505-515
- URL: https://www.wjgnet.com/2218-5836/full/v14/i7/505.htm
- DOI: https://dx.doi.org/10.5312/wjo.v14.i7.505